AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.8267
-0.0719 (-8.00%)
At close: Jun 2, 2026, 4:00 PM EDT
0.6908
-0.1359 (-16.44%)
Pre-market: Jun 3, 2026, 9:11 AM EDT
AIM ImmunoTech Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, AIM ImmunoTech stock has a consensus rating of "Buy" and an average price target of $5.25. The average 1-year stock price forecast is 535.06% higher than the current stock price, while the lowest is $1.50 (+81.44%) and the highest is $9.00 (+988.67%).
Price Target: $5.25 (+535.06%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AIM ImmunoTech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Dec '25 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $1.5 | Buy | Reiterates | $1.5 | +81.44% | Jun 2, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $22 → $10 | Buy | Maintains | $22 → $10 | +1,109.63% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
22.00K
from 88.00K
Decreased by -75.00%
Revenue Next Year
50.00K
from 22.00K
Increased by 127.27%
EPS This Year
-1.17
from -8.62
EPS Next Year
-1.18
from -1.17
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 22,000 | ||
| Avg | 22,000 | ||
| Low | 22,000 |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -75.0% | ||
| Avg | -75.0% | ||
| Low | -75.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.17 | ||
| Avg | -1.17 | ||
| Low | -1.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.